| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
DarioHealth Corp (NASDAQ: DRIO)
DRIO Technical Analysis
5
| As on 9th Jun 2023 DRIO STOCK Price closed @ 4.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.46 & Strong Sell for SHORT-TERM with Stoploss of 9.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DRIOSTOCK Price
| Open | 4.19 | Change | Price | % |
| High | 4.25 | 1 Day | -0.07 | -1.68 |
| Low | 4.07 | 1 Week | 0.20 | 5.13 |
| Close | 4.10 | 1 Month | 0.78 | 23.49 |
| Volume | 113512 | 1 Year | -9.47 | -69.79 |
| 52 Week High 13.65 | 52 Week Low 3.20 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DRIO Daily Charts |
DRIO Intraday Charts |
Whats New @ Bazaartrend |
DRIO Free Analysis |
|
|
DRIO Important Levels Intraday
| RESISTANCE | 4.45 |
| RESISTANCE | 4.34 |
| RESISTANCE | 4.27 |
| RESISTANCE | 4.20 |
| SUPPORT | 4.00 |
| SUPPORT | 3.93 |
| SUPPORT | 3.86 |
| SUPPORT | 3.75 |
DRIO Forecast May 2024
| 4th UP Forecast | 12.17 |
| 3rd UP Forecast | 9.58 |
| 2nd UP Forecast | 7.98 |
| 1st UP Forecast | 6.38 |
| 1st DOWN Forecast | 1.82 |
| 2nd DOWN Forecast | 0.22 |
| 3rd DOWN Forecast | -1.38 |
| 4th DOWN Forecast | -3.97 |
DRIO Weekly Forecast
| 4th UP Forecast | 7.14 |
| 3rd UP Forecast | 6.17 |
| 2nd UP Forecast | 5.56 |
| 1st UP Forecast | 4.96 |
| 1st DOWN Forecast | 3.24 |
| 2nd DOWN Forecast | 2.64 |
| 3rd DOWN Forecast | 2.03 |
| 4th DOWN Forecast | 1.06 |
DRIO Forecast2024
| 4th UP Forecast | 24.78 |
| 3rd UP Forecast | 18.15 |
| 2nd UP Forecast | 14.05 |
| 1st UP Forecast | 9.95 |
| 1st DOWN Forecast | -1.75 |
| 2nd DOWN Forecast | -5.85 |
| 3rd DOWN Forecast | -9.95 |
| 4th DOWN Forecast | -16.58 |
DarioHealth Corp ( NASDAQ USA Symbol : DRIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DRIO Business Profile
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York. Address: 142 West 57th Street, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service